1. Inhibition of Staphylococcus aureus cysteine proteases by human serpin potentially limits staphylococcal virulence.
- Author
-
Kantyka, Tomasz, Plaza, Karolina, Koziel, Joanna, Florczyk, Danuta, Stennicke, Hennig R., Thogersen, Ida B., Enghild, Jan J., Silverman, Gary A., Pak, Stephen C., and Potempa, Jan
- Subjects
- *
STAPHYLOCOCCUS aureus , *CYSTEINE proteinase inhibitors , *SERPINS , *MICROBIAL virulence , *PROTEOLYTIC enzymes , *PROTEOLYSIS , *ENZYME regulation - Abstract
Bacterial proteases are considered virulence factors and it is presumed that by abrogating their activity, host endogenous protease inhibitors play a role in host defense against invading pathogens. Here we present data showing that Staphylococcus aureus cysteine proteases (staphopains) are efficiently inhibited by Squamous Cell Carcinoma Antigen 1 (SCCA1), an epithelial-derived serpin. The high association rate constant ( kass) for inhibitory complex formation (1.9×104 m/s and 5.8×104 m/s for staphopain A and staphopain B interaction with SCCA1, respectively), strongly suggests that SCCA1 can regulate staphopain activity in vivo at epithelial surfaces infected/colonized by S. aureus. The mechanism of staphopain inhibition by SCCA1 is apparently the same for serpin interaction with target serine proteases whereby the formation of a covalent complex result in cleavage of the inhibitory reactive site peptide bond and associated release of the C-terminal serpin fragment. Interestingly, the SCCA1 reactive site closely resembles a motif in the reactive site loop of native S. aureus-derived inhibitors of the staphopains (staphostatins). Given that S. aureus is a major pathogen of epithelial surfaces, we suggest that SCCA1 functions to temper the virulence of this bacterium by inhibiting the staphopains. [ABSTRACT FROM AUTHOR]
- Published
- 2011
- Full Text
- View/download PDF